ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 155 filers reported holding ASCENDIS PHARMA A/S in Q3 2020. The put-call ratio across all filers is 0.38 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $3,323,000 | -75.1% | 25,258 | -75.6% | 0.00% | -80.0% |
Q1 2021 | $13,323,000 | -32.4% | 103,376 | -12.5% | 0.01% | -33.3% |
Q4 2020 | $19,700,000 | +28.1% | 118,121 | +18.5% | 0.02% | +7.1% |
Q3 2020 | $15,383,000 | +17.3% | 99,680 | +12.4% | 0.01% | +7.7% |
Q2 2020 | $13,115,000 | +114.9% | 88,678 | +63.6% | 0.01% | +85.7% |
Q1 2020 | $6,103,000 | -18.5% | 54,200 | +0.7% | 0.01% | 0.0% |
Q4 2019 | $7,485,000 | +80.3% | 53,800 | +24.8% | 0.01% | +75.0% |
Q3 2019 | $4,151,000 | +46.5% | 43,100 | +75.2% | 0.00% | +33.3% |
Q2 2019 | $2,833,000 | -11.4% | 24,600 | -9.5% | 0.00% | -25.0% |
Q1 2019 | $3,198,000 | +18.2% | 27,175 | -37.1% | 0.00% | 0.0% |
Q4 2018 | $2,706,000 | -15.7% | 43,192 | -4.6% | 0.00% | 0.0% |
Q3 2018 | $3,209,000 | +70.6% | 45,292 | +60.1% | 0.00% | +33.3% |
Q2 2018 | $1,881,000 | -35.0% | 28,281 | -36.1% | 0.00% | -25.0% |
Q1 2018 | $2,894,000 | +256.8% | 44,255 | +118.7% | 0.00% | +300.0% |
Q4 2017 | $811,000 | +13.7% | 20,235 | +2.9% | 0.00% | 0.0% |
Q3 2017 | $713,000 | +65.8% | 19,658 | +26.8% | 0.00% | 0.0% |
Q2 2017 | $430,000 | – | 15,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 5,909,742 | $911,991,000 | 16.68% |
Vivo Capital, LLC | 1,797,745 | $277,428,000 | 16.03% |
Sofinnova Investments, Inc. | 1,109,874 | $171,276,000 | 12.70% |
Asymmetry Capital Management, L.P. | 81,442 | $12,568,000 | 8.08% |
Ghost Tree Capital, LLC | 130,000 | $20,062,000 | 5.80% |
Eversept Partners, LP | 161,004 | $24,846,137 | 5.52% |
Eventide Asset Management | 1,709,848 | $263,864,000 | 5.16% |
Avoro Capital Advisors LLC | 1,800,000 | $277,776,000 | 3.95% |
BERYLSON CAPITAL PARTNERS, LLC | 72,700 | $11,219,000 | 3.93% |
Spyglass Capital Management LLC | 547,022 | $84,416,000 | 3.90% |